Medconn

Medconn Diagnostics was founded in 1992, focusing on R&D, manufacturing, sales and service of in vitro diagnostic （IVD）products. Medconn Diagnostics is headquartered in Shanghai, China. Its business covers most provinces and regions in China and its products cover HbA1c, Clinical Chemistry, Immunoassay, POCT, etc.

In 2019, we rebuilt the “Medconn Diagnostics” brand, to integrate and improve the product system, and improve the R & D capability and service quality. Medconn Diagnostics includes Hangzhou Medconn Diagnostics Technology Co., Ltd., Shanghai Medconn Medical Technology Co., Ltd., Shanghai Medconn Biotechnology Co., Ltd., and Beijing Medconn Medical Devices Co., Ltd. Of the four companies, Hangzhou Medconn Diagnostics Technology Co., Ltd. undertakes the functions of marketing center, responsible for unified external sales and service, and the other three companies undertake R & D and production functions.

Medconn Diagnostics Industrial Park is located in Jinshan District, Shanghai. It covers an area of nearly 40,000 square meters and integrates R&D, production, warehousing and logistics functions. As of 2019, the R&D system of Medconn Diagnostics has obtained 9 invention patents, 59 utility model patents, 6 design patents, 7 software Copyrights and 12 Certificates of Transformation of High-tech Achievements; The production facility of Medconn Diagnostics is certified by ISO9001, ISO13485 and GMP, with 10,000-grade purification workshops and 9500 square meters of clean workshops.

In the future, Medconn Diagnostics will continue to adhere to the business philosophy of customer orientation, and continuously improve the product and service quality through technological innovation and service innovation, so as to contribute to the vigorous development of in vitro diagnosis（IVD）industry in China.